Cargando…

Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2.

Interleukin 2 (IL-2) immunotherapy has met with limited success in the treatment of renal cell carcinoma (RCC) and malignant melanoma (MM). However, non-responders still account for up to 80% of those patients receiving IL-2. A high concentration of soluble IL-2 receptor (sIL-2R) is commonly found i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gooding, R., Riches, P., Dadian, G., Moore, J., Gore, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033994/ https://www.ncbi.nlm.nih.gov/pubmed/7640231

Ejemplares similares

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.
por: Johnston, S. R., et al.
Publicado: (1998)

Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
por: Gore, M. E., et al.
Publicado: (1992)

High-Altitude Hypoxia Decreases Plasma Erythropoietin Soluble Receptor Concentration in Lowlanders
por: Vizcardo-Galindo, Gustavo, et al.
Publicado: (2020)

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6
Publicado: (1996)

Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms
por: Keindl, Magdalena, et al.
Publicado: (2020)

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
por: Viviani, S., et al.
Publicado: (1998)

Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients
por: Downes, Kate, et al.
Publicado: (2013)

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
por: Marino, P., et al.
Publicado: (1990)

Soluble interleukin-2 receptors in ulcerative colitis
por: Nielsen, O. H., et al.
Publicado: (1993)

Positive effect of ozonotherapy on serum concentration of soluble interleukin-2 receptor and neopterin in patients with systemic sclerosis
por: Nowicka, Danuta
Publicado: (2019)

Increased plasma concentrations of interleukin 35 in patients with coronary artery disease
por: Gorzelak-Pabiś, Paulina, et al.
Publicado: (2016)

Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure
por: Cappuzzello, Claudia, et al.
Publicado: (2011)

IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production
por: Maier, Lisa M., et al.
Publicado: (2009)

Biological significance of soluble IL-2 receptor
por: Caruso, Calogero, et al.
Publicado: (1993)

Soluble ST2 plasma concentrations predict mortality in severe sepsis
por: Hoogerwerf, Jacobien J., et al.
Publicado: (2010)

Increased CSF Soluble TREM2 Concentration in Patients With Neurosyphilis
por: Li, Wurong, et al.
Publicado: (2020)

Simultaneous Analysis of Cytokines and Costimulatory Molecules Concentrations by ELISA Technique and of Probabilities of Measurable Concentrations of Interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 Occurring in Plasma of Healthy Blood Donors
por: Martin, Klabusay, et al.
Publicado: (2006)

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
por: Sobjanek, Michal, et al.
Publicado: (2016)

Elevation of soluble interleukin-2 receptor levels in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1987)

Serum Levels of Soluble Interleukin-2 Receptor in Pulmonary Tuberculosis
por: Choi, Soo Jeon, et al.
Publicado: (1990)

Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis
por: Otto, Carolin, et al.
Publicado: (2020)

Proinflammatory Soluble Interleukin-15 Receptor Alpha Is Increased in Rheumatoid Arthritis
por: Machado Diaz, Ana Cecilia, et al.
Publicado: (2012)

Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques
por: Steele, Amanda K., et al.
Publicado: (2017)

Increased soluble IL-2 receptor levels in serum from a patient with painless thyroiditis
por: Hamamoto, Kae, et al.
Publicado: (2013)

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
por: Heslegrave, Amanda, et al.
Publicado: (2016)

Serum soluble interleukin-2 receptor (sIL-2R) is an accurate biomarker for dengue-associated hemophagocytic lymphohistiocytosis syndrome diagnosed by Hscore
por: Mahabala, Chakrapani, et al.
Publicado: (2022)

Increased Serum Soluble Interleukin-2 Receptor Associated with Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhang, Yue, et al.
Publicado: (2021)

Circulating soluble LIGHT/TNFSF14 is increased and associated with IL-8 concentration in chronic spontaneous urticaria
por: Kasperska-Zając, Alicja, et al.
Publicado: (2018)

Production of Interleukin-2 (IL-2) and Expression of IL-2 Receptor in Patients with IgA Nephropathy
por: Lee, Tae-Won, et al.
Publicado: (1992)

Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum
por: Ravi, Arjun K, et al.
Publicado: (2014)

Thapsigargin Increases IL-2 Production in T Cells at Nanomolar Concentrations
por: Kim, Ki-Hyang, et al.
Publicado: (2018)

Preeclampsia Status Controls Interleukin-6 and Soluble IL-6 Receptor Release from Neutrophils and Endothelial Cells: Relevance to Increased Inflammatory Responses
por: Wang, Yuping, et al.
Publicado: (2021)

Plasma levels of soluble ST2, but not IL‐33, correlate with the severity of alcoholic liver disease
por: Sun, Zijian, et al.
Publicado: (2018)

Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis
Publicado: (1995)

A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma.
por: Ahmed, F. Y., et al.
Publicado: (1996)

Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels
por: Stone, Katie, et al.
Publicado: (2013)

Detection of soluble interleukin-2 receptor and soluble intercellular adhesion molecule-1 in the effusion of otitis media with effusion
por: Ganbo, T., et al.
Publicado: (1995)

Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients
por: Zhang, Yaguang, et al.
Publicado: (2020)

Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.
por: Zielinski, C. C., et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_6db62en012gle3a3ih97lrmr91